tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Roche Holding (RHHBY)
OTHER OTC:RHHBY
RHHBY
Roche Holding
Stock Analysis
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding RHHBY?
Track your performance easily
Link Broker

Roche Holding (RHHBY) Stock News & Sentiment

1,426 Followers
Roche opens Pharma Research and Development Center in Basel to accelerate scientific innovation
Premium
Press Releases
Roche opens Pharma Research and Development Center in Basel to accelerate scientific innovation
1d ago
Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis
Premium
Press Releases
Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis
8d ago
Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
Premium
Press Releases
Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
16d ago
Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak
Premium
Press Releases
Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak
22d ago
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
Premium
Market News
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
27d ago
MRK
SNY
European Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO)
Premium
Press Releases
European Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO)
1M ago
Eli Lilly (NYSE:LLY) Gains despite Rising Competition for Weight Loss Drugs
Premium
Market News
Eli Lilly (NYSE:LLY) Gains despite Rising Competition for Weight Loss Drugs
1M ago
LLY
More RHHBY News >

RHHBY News on the Web

UBS Sticks to Its Hold Rating for Roche Holding AG (RHHVF)
TipRanks News
Neutral
The Zacks Analyst Blog Amazon, Roche, GE Aerospace, Canterbury Park and NVE
Zacks
Neutral
Roche Expands Digital Pathology With More Than 20 AI Algorithms From Eight New Partners
rttnews
Neutral
Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment
Yahoo Finance
Neutral
Top Analyst Reports for Amazon.com, Roche & GE Aerospace
Zacks
Neutral
Berenberg Bank Keeps Their Hold Rating on Roche Holding AG (RHHVF)
TipRanks News
Neutral
Merck Starts Late-Stage Study on Recently Acquired Ophthalmology Drug
Zacks
Neutral
Affimed Appoints New CEO, Shares Fall on Leadership Change
Zacks
Neutral

News Score - Last 7 Days

Neutral
RHHBY
Sector Average
Media Buzz
This Week10 articles
Weekly Average8 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RHHBY’s Media Buzz Sentiment?
10 articles about RHHBY were published this week. In an average week, 8 articles are published.
    What is RHHBY’s weekly average amount of articles?
    In an average week, 8 articles about RHHBY are published.
      What is RHHBY’s News Sentiment?
      50% of articles about RHHBY were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        VORVor Biopharma
        STESteris
        IMVTImmunovant
        PBHPrestige Consumer Healthcare
        AMLXAmylyx Pharmaceuticals Inc
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing